CD80 antibody (APC)
Quick Overview for CD80 antibody (APC) (ABIN375397)
Target
See all CD80 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- Mouse CD80, Mr 52-55 kDa
-
Characteristics
- Rat Anti-Mouse CD80-APC
-
Purification
- Purified
-
Immunogen
- Activated 5C2 cells
-
Isotype
- IgG2a
-
-
-
-
Application Notes
-
- Applications: FC - Quality tested , IP - Reported in literature , Block - Reported in literature
- Working Dilutions: Flow Cytometry FITC and BIOT conjugates 1 g/106 cells PE, APC, and SPRD conjugates 0.2 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L
-
Comment
-
In vivo and in vitro blocking of ligand binding
-
Sample Volume
- 1 mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.1 mg/mL
-
Buffer
- 0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
-
Do not freeze!
Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed. -
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C
-
-
- CD80
-
Alternative Name
- CD80
-
Background
- CD80 (B7-1) is a type I transmembrane glycoprotein and a member of the immunoglobulin superfamily of cell surface receptors. It is constitutively expressed by dendritic cells, monocytes, and peritoneal macrophages. Expression of CD80 on B cells is upregulated after activation by various means including stimulation by LPS, IL-4, and surface Ig receptor cross linking with peak expression occurring between 48 and 72 hours post-activation. The interaction of CD80/B7-1 with its ligands, CD28 and CD152/CTLA-4, provides a potent costimulatory signal for T cells activated through the CD3/T cell receptor complex.
-
Pathways
- TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-